BEIJING -- A group of Chinese researchers has developed a wearable repetitive transcranial magnetic stimulation (rTMS) device ...

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

The world's best clinics achieve success in Parkinson’s treatment by individualizing deep brain stimulation (DBS) through ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Ultrasound-based technologies are emerging as promising noninvasive approaches to treat brain disorders ... beam location and focusing in a closed-loop system. The tcMRgHIFU approach possesses ...

An update to the traditional deep brain stimulation device enables adaptive pulses of electricity that help to lessen the symptoms of Parkinson’s disease and inform future research.

Newronika's AlphaDBS monitors the patient's brain activity and automatically adjusts stimulation levels in response to ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

This stimulation, in turn ... This is the first time a so-called ‘closed loop’ brain implant technology has been shown to work in Parkinson’s patients as they go about their daily lives.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...